Table 2.
GO analysis of candidate targets for FSG against CRF.
| Category | Term | Count | % | P value | FDR |
|---|---|---|---|---|---|
| GOTERM_BP_DIRECT | GO: 0045944 ∼ positive regulation of transcription from RNA polymerase II promoter | 15 | 0.116505 | 7.96E − 07 | 0.001275 |
| GOTERM_BP_DIRECT | GO: 0006954 ∼ inflammatory response | 9 | 0.069903 | 3.04E − 05 | 0.048613 |
| GOTERM_BP_DIRECT | GO: 0010629 ∼ negative regulation of gene expression | 8 | 0.062136 | 1.68E − 07 | 2.70E − 04 |
| GOTERM_BP_DIRECT | GO: 0001666 ∼ response to hypoxia | 7 | 0.054369 | 1.51E − 06 | 0.002417 |
| GOTERM_BP_DIRECT | GO: 0045766 ∼ positive regulation of angiogenesis | 7 | 0.054369 | 4.47E − 06 | 0.007153 |
| GOTERM_BP_DIRECT | GO: 0043066 ∼ negative regulation of apoptotic process | 7 | 0.054369 | 1.83E − 03 | 2.882482 |
| GOTERM_BP_DIRECT | GO: 0006351 ∼ transcription, DNA-templated | 7 | 0.054369 | 1.21E − 02 | 17.70194 |
| GOTERM_BP_DIRECT | GO: 0006979 ∼ response to oxidative stress | 6 | 0.046602 | 2.45E − 05 | 0.03918 |
| GOTERM_BP_DIRECT | GO: 0001525 ∼ angiogenesis | 6 | 0.046602 | 3.80E − 04 | 0.605925 |
| GOTERM_BP_DIRECT | GO: 0010628 ∼ positive regulation of gene expression | 6 | 0.046602 | 8.81E − 04 | 1.40093 |
| GOTERM_MF_DIRECT | GO: 0005125 ∼ cytokine activity | 11 | 0.085437 | 6.08E − 09 | 7.57E − 06 |
| GOTERM_MF_DIRECT | GO: 0020037 ∼ heme binding | 8 | 0.062136 | 7.12E − 06 | 0.008875 |
| GOTERM_MF_DIRECT | GO: 0043565 ∼ sequence-specific DNA binding | 8 | 0.062136 | 2.47E − 03 | 3.030466 |
| GOTERM_MF_DIRECT | GO: 0008083 ∼ growth factor activity | 7 | 0.054369 | 1.00E − 06 | 0.001248 |
| GOTERM_MF_DIRECT | GO: 0004252 ∼ serine-type endopeptidase activity | 6 | 0.046602 | 1.17E − 03 | 1.447175 |
| GOTERM_MF_DIRECT | GO: 0042802 ∼ identical protein binding | 5 | 0.038835 | 1.21E − 04 | 0.151175 |
| GOTERM_MF_DIRECT | GO: 0002020 ∼ protease binding | 4 | 0.031068 | 4.22E − 04 | 0.524268 |
| GOTERM_MF_DIRECT | GO: 0003707 ∼ steroid hormone receptor activity | 4 | 0.031068 | 4.95E − 03 | 6.000497 |
| GOTERM_MF_DIRECT | GO: 0042803 ∼ protein homodimerization activity | 4 | 0.031068 | 1.19E − 02 | 13.83665 |
| GOTERM_MF_DIRECT | GO: 0004937 ∼ alpha1-adrenergic receptor activity | 3 | 0.023301 | 1.36E − 04 | 0.169113 |
| GOTERM_CC_DIRECT | Extracellular space | 26 | 0.201942 | 3.25E − 13 | 3.77E − 10 |
| GOTERM_CC_DIRECT | GO: 0070062 ∼ extracellular exosome | 18 | 0.139806 | 7.97E − 03 | 8.860488 |
| GOTERM_CC_DIRECT | GO: 0005829 ∼ cytosol | 16 | 0.124272 | 1.18E − 05 | 0.013679 |
| GOTERM_CC_DIRECT | GO: 0005794 ∼ Golgi apparatus | 9 | 0.069903 | 1.16E − 03 | 1.340888 |
| GOTERM_CC_DIRECT | GO: 0005576 ∼ extracellular region | 9 | 0.069903 | 2.31E − 03 | 2.648495 |
| GOTERM_CC_DIRECT | GO: 0045121 ∼ membrane raft | 7 | 0.054369 | 6.90E − 06 | 0.007999 |
| GOTERM_CC_DIRECT | GO: 0009897 ∼ external side of plasma membrane | 7 | 0.054369 | 6.50E − 05 | 0.075398 |
| GOTERM_CC_DIRECT | GO: 0009986 ∼ cell surface | 7 | 0.054369 | 3.62E − 03 | 4.113532 |
| GOTERM_CC_DIRECT | GO: 0031012 ∼ extracellular matrix | 6 | 0.046602 | 1.67E − 04 | 0.19341 |
| GOTERM_CC_DIRECT | GO: 0005925 ∼ focal adhesion | 6 | 0.046602 | 1.08E − 02 | 11.87756 |